What is the primary purpose of this 8-K filing?

The primary purpose of this 8-K filing is to announce the appointment of James D. Clark as the new Senior Vice President – Controller and Chief Accounting Officer of CVS Health, which is contingent upon the closing of the Aetna acquisition.

When will James D. Clark's appointment become effective?

Mr. Clark's appointment will be effective on the closing date of the proposed acquisition of Aetna Inc.

What are the key changes in compensation for James D. Clark?

Upon his appointment, Mr. Clark's annual salary will increase to $400,000. His 2018 target annual cash incentive award will be 45% of his salary, and he will continue to participate in equity incentive plans with an aggregate target of 137% of his salary.

How does this filing relate to the Aetna acquisition?

This filing is directly tied to the Aetna acquisition as Mr. Clark's appointment is effective upon its closing. It also confirms the planned transition of Eva Boratto to CFO post-acquisition, indicating progress in the integration planning for key financial roles.

CVS 8-K: Leadership Changes & Regulation FD

Summary

CVS Health Corporation filed an 8-K report on October 22, 2018, primarily announcing a key executive appointment following the anticipated acquisition of Aetna Inc. James D. Clark has been appointed Senior Vice President – Controller and Chief Accounting Officer, effective upon the closing of the Aetna acquisition. This appointment is a significant step in integrating the leadership of the combined entity and ensuring financial stewardship post-merger. This filing also indirectly references the ongoing progress of the Aetna acquisition by detailing the new role for Mr. Clark and confirming the previously announced transition for Eva Boratto to Executive Vice President and Chief Financial Officer. Investors should note that the compensation details for Mr. Clark's new role have been disclosed, including an increased salary and incentive awards, reflecting his expanded responsibilities. The report also reiterates the company's ongoing communication regarding the Aetna transaction, including references to prior filings and public announcements.

Key Highlights

1Appointment of James D. Clark as Senior Vice President – Controller and Chief Accounting Officer, effective upon closing of the Aetna acquisition.
2Mr. Clark's prior experience includes 22 years at Deloitte & Touche LLP, with eight years as an audit partner, and current role as Vice President – Finance and Accounting at CVS Health since 2009.
3Eva Boratto, current Controller and Chief Accounting Officer, will transition to Executive Vice President and Chief Financial Officer post-acquisition.
4James D. Clark's new role includes an annual salary of $400,000, a 2018 target annual cash incentive award of 45% of salary, and continued participation in equity incentive plans with a target of 137% of salary.
5The report references an accompanying announcement (Exhibit 99.1) detailing these executive changes.
6The filing includes standard legal disclaimers and information on where to find additional documents related to the Aetna acquisition, including the Form S-4 registration statement.

CVS HEALTH Corp 8-K Report, Executive Changes (Oct 22, 2018)

Summary

Key Highlights

Frequently Asked Questions